Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel method of differentiating human induced pluripotent stem cells to mature cardiomyocytes via Sfrp2

9 Mar 2023

Abstract excerpt

Current methods to generate cardiomyocytes from induced pluripotent stem cells (iPSc) utilize broad-spectrum pharmacological inhibitors. These methods give rise to cardiomyocytes which are typically immature. Since we have recently demonstrated that cardiomyogenesis in vitro and in vivo requires Sfrp2, we asked if Sfrp2 would drive differentiation of human iPSc into cardiomyocytes. Indeed, we found that Sfrp2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital heart defects research
Share to Pluripotent Stem Cells Research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36894665
DOI: 10.1038/s41598-023-31144-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel method of differentiating human induced pluripotent stem cells to mature cardiomyocytes via Sfrp2PMID 36894665Read ↗

Induced Pluripotent Stem Cells: A New Dawn for the Treatment of Ischemic CardiomyopathySemantic proximity Read ↗

How to mend a broken heart: adult and induced pluripotent stem cell therapy for heart repair and regeneration.Semantic proximity Read ↗

Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblastsSemantic proximity Read ↗

Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic ToolsSemantic proximity Read ↗

Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitorsSemantic proximity Read ↗

In vitro uses of human pluripotent stem cell-derived cardiomyocytes.Semantic proximity Read ↗

Functional cardiomyocytes derived from human induced pluripotent stem cells.Semantic proximity Read ↗

A modified method for isolation of human cardiomyocytes to model cardiac diseasesSemantic proximity Read ↗

Induced pluripotent stem cells in cardiovascular drug discovery.Semantic proximity Read ↗

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule InductionSemantic proximity Read ↗

CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).Semantic proximity Read ↗

Functional isolation, culture and cryopreservation of adult human primary cardiomyocytesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.